Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
62.55
+3.00 (5.04%)
Nov 20, 2024, 4:00 PM EST - Market closed
Disc Medicine Employees
Disc Medicine had 74 employees as of December 31, 2023. The number of employees increased by 28 or 60.87% compared to the previous year.
Employees
74
Change (1Y)
28
Growth (1Y)
60.87%
Revenue / Employee
n/a
Profits / Employee
-$1,398,365
Market Cap
1.86B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 74 | 28 | 60.87% |
| Dec 31, 2022 | 46 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 18,000 |
| Patterson Companies | 7,600 |
| Integra LifeSciences Holdings | 3,946 |
| NovoCure | 1,453 |
| AtriCure | 1,200 |
| Galapagos NV | 1,123 |
| Recursion Pharmaceuticals | 500 |
| Xencor | 280 |
IRON News
- 8 days ago - Disc Medicine to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 13 days ago - Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc. - GlobeNewsWire
- 17 days ago - Disc Medicine Announces Successful End of Phase 2 Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP), Including Potential for Accelerated Approval - GlobeNewsWire
- 19 days ago - Disc Medicine to Host Conference Call on End of Phase 2 FDA Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP) - GlobeNewsWire
- 26 days ago - Disc Medicine Presents Positive Data from SAD Cohorts of a Phase 1b Trial in Patients with Chronic Kidney Disease (CKD) and Anemia at the 2024 American Society of Nephrology (ASN) Kidney Week - GlobeNewsWire
- 5 weeks ago - Disc Medicine Announces Presentation of New Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2024 American Society of Nephrology (ASN) Kidney Week - GlobeNewsWire
- 2 months ago - Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Steve Caffé, MD as Chief Regulatory Officer - GlobeNewsWire
- 5 months ago - Disc Medicine: Hematological Disorders Treatment Advances With DISC-0974 Progress - Seeking Alpha